---
title: "688221.SH (688221.SH) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/688221.SH/news.md"
symbol: "688221.SH"
name: "688221.SH"
parent: "https://longbridge.com/en/quote/688221.SH.md"
datetime: "2026-05-21T03:13:45.927Z"
locales:
  - [en](https://longbridge.com/en/quote/688221.SH/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/688221.SH/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/688221.SH/news.md)
---

# 688221.SH (688221.SH) — Related News

### [The highest increase was 40 times! 58 pharmaceutical companies doubled their net profit attributable to shareholders in the first quarter. What is the reason?](https://longbridge.com/en/news/286044018.md)
*2026-05-12T06:06:07.000Z*
> In the first quarter of 2026, the net profit attributable to the parent company of 58 pharmaceutical enterprises doubled

### [From "the first stock against AIDS" to a new star in small nucleic acids, Frontier Biotechnologies' stock price and performance soar together, hitting the limit up against the trend thanks to a $10 million licensing fee from GSK](https://longbridge.com/en/news/284198977.md)
*2026-04-27T10:47:19.000Z*
> Froniter Biotechnologies saw its stock price hit the daily limit upward, closing at 22.74 yuan per share, despite a gene

### [Shanghai Stock Connect and Hangzhou gang buy Frontier Biotechnologies, Wenzhou gang cashes out Holitech 130 million yuan](https://longbridge.com/en/news/284187681.md)
*2026-04-27T09:37:20.000Z*
> On April 27th, the Shanghai Composite Index rose by 0.16%, the Shenzhen Component Index rose by 0.37%, and the ChiNext I

### [Froniter Biotechnologies: Net profit of 227 million yuan in the first quarter](https://longbridge.com/en/news/283986045.md)
*2026-04-24T10:58:33.000Z*
> Froniter Biotechnologies announced that its operating revenue in the first quarter of 2026 was 297 million yuan, compare

### [The chemical formulation sector has seen a short-term surge](https://longbridge.com/en/news/283923512.md)
*2026-04-24T02:35:08.000Z*
> The chemical formulation sector saw a short-term surge, with GOLDSTONE ASIA PHARM and ApicHope rising over 10%, while GL

### [750 million! Origin Biotech completes Pre-IPO round of financing with Qiming Venture Partners continuing to invest](https://longbridge.com/en/news/282447436.md)
*2026-04-12T13:22:22.000Z*
> Oricell recently completed a Pre-IPO round of financing amounting to $110 million (approximately 751 million RMB), prima

### [Deeply cultivating the field of cell therapy drugs, Origin Biologics has completed a $110 million Pre-IPO round of financing](https://longbridge.com/en/news/282272324.md)
*2026-04-10T01:44:09.000Z*
> Origin Biologics has completed a $110 million Pre-IPO round of financing, led by Weifu Capital and others. The funds wil

### [Froniter Biotechnologies: FB4001 has submitted an ANDA registration application to the U.S. FDA and passed the FDA's pre-approval inspection with zero defects](https://longbridge.com/en/news/279742465.md)
*2026-03-19T07:44:16.000Z*
> On March 19th, Froniter Biotechnologies stated on the interactive platform that the company’s FB4001 (teriparatide injec

### [Secured a $40 million upfront payment! This innovative pharmaceutical company partners with a global pharmaceutical giant | Selected After-Hours Announcements](https://longbridge.com/en/news/279607808.md)
*2026-03-18T13:03:20.000Z*
> Froniter Biotechnologies signed a licensing agreement with GSK and received a $40 million upfront payment. A subsidiary 

### [Froniter Biotechnologies: FB7013 injection has received approval for clinical trials](https://longbridge.com/en/news/279555979.md)
*2026-03-18T08:17:03.000Z*
> Froniter Biotechnologies recently received approval from the National Medical Products Administration for the clinical t